Photos from Envato
This is the highest-growing area of therapy of the year.
GlobalData said the global central nervous system (CNS) market is expected to exceed $80B in sales in 2025, marking the first time it has returned to that level since 2013.
Driven by powerful multiple sclerosis (MS) drug sales and advances in psychiatric drug development, CNS sees CNS as the fifth-level growing therapeutic area of the year.
In addition, the development of neuroimmunology and neurodegenerative contributes to market growth.
High research and development costs, clinical challenges, and setbacks in Alzheimer's disease and amyotrophic lateral sclerosis have previously slowed investment in central nervous system therapeutics, said Globaldata's drug analyst Eleni Tokali.
Tokali added: “The CNS market is at a turning point. With breakthroughs in psychiatry, Alzheimer’s and MS, Pharma is moving towards more diverse and sustainable neuro and psychotropic drug development.”
Join the Healthcare Asia Magazine Community
Since you're here…
…You can promote your company with us and connect with your customers in a variety of ways. Our team can help you Dight and create advertising campaigns on print and digitally on this website and on print magazines.
We can also organize real-life or digital events for you and find thought leader speakers and industry leaders who can become your potential partners to attend. We also run a number of award programs that give you the opportunity to earn your achievements this year and you can join as a participant or sponsor.
Let us help you move your business forward with a good partnership!
